Hepatocellular carcinoma
The Lancet - Early Online Publication,  Clinical Article

Forner A et al. – Findings of randomised trials of sorafenib have shown survival benefits for individuals with advanced hepatocellular carcinoma, suggesting that molecular–targeted therapies could be effective in this chemoresistant cancer. Research is active in the area of pathogenesis and treatment of hepatocellular carcinoma.

  • Hepatocellular carcinoma is the sixth most prevalent cancer and the third most frequent cause of cancer–related death.
  • Patients with cirrhosis are at highest risk of developing this malignant disease, and ultrasonography every 6 months is recommended.
  • Surveillance with ultrasonography allows diagnosis at early stages when the tumour might be curable by resection, liver transplantation, or ablation, and 5–year survival higher than 50% can be achieved.
  • Patients with small solitary tumours and very well preserved liver function are the best candidates for surgical resection.
  • Liver transplantation is most beneficial for individuals who are not good candidates for resection, especially those within Milano criteria (solitary tumour ≤5 cm and up to three nodules ≤3 cm).
  • Donor shortage greatly limits its applicability.
  • Percutaneous ablation is the most frequently used treatment but its effectiveness is limited by tumour size and localisation.
  • In asymptomatic patients with multifocal disease without vascular invasion or extrahepatic spread not amenable to curative treatments, chemoembolisation can provide survival benefit.

Please login or register to follow this author.
► Click here to access PubMed, Publisher and related articles...
<< Previous Article | Next Article >>

Your Unread Messages in Gastroenterology

See All >> Messages include industry-sponsored communications and special communications from MDLinx

Most Popular Gastroenterology Articles

1 Screening prior to biological therapy in Crohn's disease: Adherence to guidelines and prevalence of infections. Results from a multicentre retrospective study Digestive and Liver Diseases, August 4, 2014    Clinical Article

2 The probiotic VSL#3 has anti-inflammatory effects and could reduce endoscopic recurrence following surgery for Crohn's disease Clinical Gastroenterology and Hepatology , November 7, 2014    Clinical Article

3 Systematic review: new serological markers (anti-glycan, anti-GP2, anti-GM-CSF Ab) in the prediction of IBD patient outcomes Autoimmunity Reviews, November 19, 2014    Evidence Based Medicine    Review Article

4 Higher vitamin D serum concentration increases health related quality of life in patients with inflammatory bowel diseases Full Text World Journal of Gastroenterology, November 17, 2014    Free full text    Clinical Article

5 Magnetic resonance enterocolonography is highly detectable of erosion and redness in intestinal mucosa of patients with Crohn's disease Journal of Gastroenterology and Hepatology, November 20, 2014    Clinical Article

6 Risk of lymphoma in patients with inflammatory bowel disease treated with azathioprine and 6-mercaptopurine: a meta-analysis Clinical Gastroenterology and Hepatology , June 25, 2014    Evidence Based Medicine    Clinical Article

7 Predictors of response to steroid therapy for eosinophilic esophagitis and treatment of steroid-refractory patients Clinical Gastroenterology and Hepatology , September 19, 2014    Clinical Article

8 Re-treatment of chronic hepatitis C virus genotype 1 infection after relapse: an open-label pilot study Annals of Internal Medicine, November 11, 2014    Evidence Based Medicine    Clinical Article

9 Clinical utility and diagnostic accuracy of faecal calprotectin for IBD at first presentation to gastroenterology services in adults aged 16-50years Journal of Crohn's and Colitis, September 8, 2014    Clinical Article

10 Lactulose vs polyethylene glycol 3350-electrolyte solution for treatment of overt hepatic encephalopathy: the help randomized clinical trial JAMA Internal Medicine, October 13, 2014    Evidence Based Medicine    Clinical Article

11 The use of sirolimus (rapamycin) in the management of refractory inflammatory bowel disease in children Journal of Crohn's and Colitis, November 3, 2014    Clinical Article

12 The impact of timing and duration of thiopurine treatment on colectomy in ulcerative colitis: A national population-based study of incident cases between 1989–2009 Alimentary Pharmacology and Therapeutics, November 12, 2014    Clinical Article

13 Consumption of garlic and risk of colorectal cancer: An updated meta-analysis of prospective studies Full Text World Journal of Gastroenterology, November 18, 2014    Free full text    Evidence Based Medicine

14 Association between serrated polyps and the risk of synchronous advanced colorectal neoplasia in average-risk individuals Alimentary Pharmacology and Therapeutics, October 27, 2014    Clinical Article

15 Idiopathic inflammatory demyelinating disease of the central nervous system in patients with inflammatory bowel disease: retrospective analysis of 9095 patients Alimentary Pharmacology and Therapeutics, November 4, 2014    Clinical Article

16 Timing of rebleeding in high-risk peptic ulcer bleeding after successful hemostasis: A systematic review Canadian Journal of Gastroenterology, November 12, 2014    Review Article

17 Risk of lymphoma in patients with inflammatory bowel disease treated with azathioprine and 6-mercaptopurine: a meta-analysis Clinical Gastroenterology and Hepatology , September 25, 2014    Clinical Article

18 The relationship between infliximab concentrations, antibodies to infliximab and disease activity in Crohn's disease Gut, November 13, 2014    Clinical Article

19 High-dose dual therapy is superior to standard first-line or rescue therapy for Helicobacter pylori infection Clinical Gastroenterology and Hepatology , November 21, 2014    Clinical Article

20 Risk of upper gastrointestinal bleeding from different drug combinations Gastroenterology, October 13, 2014    Clinical Article

Indexed Journals in Gastroenterology: Gastroenterology, American Journal of Gastroenterology, Gutmore